XML 47 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation (Tables)
9 Months Ended
Oct. 28, 2017
Share-Based Compensation [Abstract]  
Total Compensation Expense and the Related Tax Benefits Recognized



 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Thirteen weeks ended

 

Thirty-nine weeks ended



October 28,

 

October 29,

 

October 28,

 

October 29,



2017

 

2016

 

2017

 

2016



($ in millions)

Options and shares purchased under the employee stock purchase plan

$

 

$

 

$

 

$

Restricted stock and restricted stock units

 

 

 

 

 

 

 

Total share-based compensation expense 

$

 

$

 

$

11 

 

$

17 



 

 

 

 

 

 

 

 

 

 

 

Tax benefit recognized

$

 

$

 

$

 

$



Assumptions used to Compute Share-Based Compensation Expense



 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Stock Option Plans

 

 

Stock Purchase Plan

 



 

October 28,

 

 

October 29,

 

 

October 28,

 

 

October 29,

 



 

2017

 

 

2016

 

 

2017

 

 

2016

 

Weighted-average risk free rate of interest

 

2.1 

%

 

1.4 

%

 

0.9 

%

 

0.4 

%

Expected volatility

 

25 

%

 

30 

%

 

29 

%

 

27 

%

Weighted-average expected award life (in years)

 

5.4 

 

 

5.7 

 

 

1.0 

 

 

1.0 

 

Dividend yield

 

1.9 

%

 

1.7 

%

 

2.0 

%

 

1.7 

%

Weighted-average fair value

$

14.74 

 

$

15.71 

 

$

10.84 

 

$

14.04 

 



Options Granted under Stock Option Plans



 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

   

 

 

Weighted-

 

Weighted-



 

 

Number

 

Average

 

Average



 

 

of

 

Remaining

 

Exercise



 

 

Shares

 

Contractual Life

 

Price



 

 

(in thousands)

 

(in years)

 

(per share)

Options outstanding at the beginning of the year

 

 

2,806 

 

 

 

 

$

42.61 

Granted

 

 

547 

 

 

 

 

 

69.58 

Exercised

 

 

(536)

 

 

 

 

 

21.38 

Expired or cancelled

 

 

(19)

 

 

 

 

 

61.01 

Options outstanding at October 28, 2017

 

 

2,798 

 

 

6.7 

 

$

51.82 

Options exercisable at October 28, 2017

 

 

1,729 

 

 

5.4 

 

$

42.91 

Options available for future grant at October 28, 2017

 

 

10,759 

 

 

 

 

 

 



Total Intrinsic Value of Options Exercised



 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 



Thirteen weeks ended

 

Thirty-nine weeks ended



October 28,

 

October 29,

 

October 28,

 

October 29,



2017

 

2016

 

2017

 

2016



($ in millions)

Exercised

$

 

$

19 

 

$

20 

 

$

45 



Aggregate Intrinsic Value for Stock Options Outstanding and Exercisable



 

 

 

 

 



 

 

 

 

 



Thirty-nine weeks ended



October 28,

 

October 29,



2017

 

2016



($ in millions)

Outstanding

$

 

$

78 

Outstanding and exercisable

$

 

$

71 

Vested and expected to vest

$

 

$

78 



Information about Stock Options Outstanding and Exercisable



 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Options Outstanding

 

Options Exercisable



 

 

   

Weighted-

   

 

 

 

 

 

   

 



 

 

 

Average

 

 

Weighted-

 

 

 

 

Weighted-



 

 

 

Remaining

 

 

Average

 

 

 

 

Average

Range of Exercise

 

Number

 

Contractual

 

 

Exercise

 

Number

 

 

Exercise

Prices

 

Outstanding

 

Life

 

 

Price

 

Exercisable

 

 

Price



 

(in thousands, except prices per share and contractual life)

$9.85 to $24.75

 

344 

 

2.7 

 

$

16.77 

 

344 

 

$

16.77 

$30.92 to $45.75

 

787 

 

5.5 

 

 

38.33 

 

747 

 

 

38.50 

$48.55 to $62.11

 

704 

 

6.9 

 

 

61.05 

 

472 

 

 

61.35 

$63.79 to $73.21

 

963 

 

8.8 

 

 

68.60 

 

166 

 

 

64.35 



 

2,798 

 

6.7 

 

$

51.82 

 

1,729 

 

$

42.91 



Restricted Share and Unit Activity



 

 

 

 

 

 

 



 

 

 

Weighted-

 

 

 



   

 

 

Average

 

Weighted-



 

Number

 

Remaining

 

Average



 

of

 

Contractual

 

Grant Date



 

Shares

 

Life

 

Fair Value



 

(in thousands)

 

(in years)

 

 

(per share)

Nonvested at beginning of year

 

798 

 

 

 

$

56.91 

Granted

 

328 

 

 

 

 

63.72 

Vested

 

(286)

 

 

 

 

49.55 

Expired or cancelled

 

(447)

 

 

 

 

64.74 

Nonvested at October 28, 2017

 

393 

 

1.5 

 

$

59.07 

Aggregate value ($ in millions)

 $

23